Target intelligence / Profile preview

Clustered high-mannose-type N-glycans (HM-glycans)

Target
HM-glycans
Molecular classification
Carbohydrate, Post-translational modification, Glycan
01

Overview

Clustered high-mannose-type N-glycans are dense arrays of oligomannose structures found on the surface of specific viral glycoproteins, most prominently the HIV-1 envelope protein gp120 (Crispin et al., 2018, Immunity). While high-mannose glycans are typically transient intermediates in human protein glycosylation, the high density of glycans on certain viruses prevents processing enzymes from converting them into complex sugars, resulting in a persistent mannose patch (Doores, 2015, FEBS Letters). This cluster functions as a glycan shield that hides underlying protein epitopes from the host immune system, facilitating viral persistence. However, this unique density allows for the specific binding of broadly neutralizing antibodies (bnAbs) and certain lectins, which do not typically bind to the more sparse high-mannose glycans found on host cells (Scanlan et al., 2002, J. Virol.). Consequently, these clusters are a primary focus for the development of HIV vaccines and entry-inhibitor therapies designed to neutralize the virus and prevent infection (Watanabe et al., 2019, Nature Communications).

Other names
Mannose patchOligomannose-type N-glycansHigh-mannose glycan shieldMan9GlcNAc2 clustersViral glycan shield
02

Mechanism of action

Binding to the dense glycan cluster on viral envelopes to sterically block receptor binding or prevent the conformational changes necessary for viral-cell membrane fusion.

03

Biological functions

Immune evasionProtein foldingViral entryCell-cell recognition
04

Disease associations

InfectionCancer
05

Safety considerations

Potential cross-reactivity with host high-mannose glycans in the ER/GolgiImmunogenicity of non-human lectinsRapid viral mutation leading to glycan hole shifts
06

Interacting drugs

2G12

6 more in the full profile.

07

Biomarkers

HIV-1 gp120 glycoform profileAnti-mannose antibody titers

Beyond the preview

Go deeper on Clustered high-mannose-type N-glycans (HM-glycans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clustered high-mannose-type N-glycans (HM-glycans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call